A scientist at the Academy of Military Medical Sciences says too many research institutions are working on a Sars vaccine, leading to a duplication of efforts and a waste of resources. Zhu Qingyu's institute, which is leading one of two state-supported efforts to develop a vaccine, said the situation was chaotic. 'Everybody is doing their own thing. I am afraid there is going to be a lot of duplication and it will be wasteful,' Dr Zhu said. 'The government should take this into consideration. I believe the government will only support two or three institutions, but everybody is doing it and the government cannot control them.' Dr Zhu said the problem with scientific research on the mainland was that people tended to jump on the bandwagon. 'A few years ago everybody was doing genetic engineering and bio-medical research.' However, he said some competition was good, as the quality of research would be higher and results could be achieved faster if more than one institute was researching a subject. Dr Zhu said his team was making good progress, but could not yet reveal details of work carried out. 'Even though we are doing well so far, testing of the vaccine will take a long time and if we are not successful at the testing stage it's going to delay development of the vaccine,' he said. The Guangzhou-based New Express said Dr Zhu's team and another team headed by the Chinese Centre for Disease Control and Prevention had already completed a first round of testing the vaccine on monkeys. There are other teams in Guangdong and Shanghai working on a vaccine, while in Beijing alone more than 10 high-protection biological laboratories have been built at a cost of millions of yuan for vaccine research, the report said. Dr Zhu and his team discovered coronavirus particles in the brain tissue of mice as early as February 19, but the findings were not announced until April 11, about three weeks after the University of Hong Kong revealed it had discovered the coronavirus.